{"id":"W4254247120","doi":"10.1155/2010/165926","title":"Challenges in Initiating Antiretroviral Therapy in 2010","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Protease inhibitor (pharmacology); Nucleoside Reverse Transcriptase Inhibitor; Antiretroviral therapy; Reverse transcriptase; Reverse-transcriptase inhibitor; Population; Clinical trial; Ritonavir; Adverse effect; Drug; Infectivity; Intensive care medicine; Human immunodeficiency virus (HIV); Virology; Pharmacology; Immunology; Viral load; Internal medicine; Virus; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01498508,0.0005792478,0.0008178646,0.0007626718,0.002223224,0.004621856,0.001470169,0.006596536,0.01726714],"category_scores_gemma":[0.03349145,0.0003579494,0.0009584329,0.000989748,0.0009340802,0.004979883,0.003329559,0.01124752,0.007444046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003606813,"about_ca_system_score_gemma":0.008983285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009983033,"about_ca_topic_score_gemma":0.01862617,"domain_scores_codex":[0.9909719,0.002561792,0.00175386,0.000707412,0.003194363,0.0008107486],"domain_scores_gemma":[0.9857943,0.003757673,0.001455181,0.0004382186,0.003589641,0.004964899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001829399,0.0002495721,0.00619822,0.0006847694,0.00004293443,0.001338806,0.0006738664,0.0003426596,0.0003432997,0.01344709,0.4906326,0.4858634],"study_design_scores_gemma":[0.0000414802,0.0001725777,0.006500106,0.002114334,0.00003325439,0.002249654,0.0007122957,0.0003837962,0.0001289787,0.006202518,0.981425,0.0000359869],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.005556027,0.06751653,0.002748988,0.8530465,0.01974361,0.0001141488,0.0007170838,0.0002254923,0.05033164],"genre_scores_gemma":[0.1005207,0.1454007,0.01544439,0.6461809,0.04594665,0.0003038718,0.00242283,0.0003190374,0.04346092],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01726714,"threshold_uncertainty_score":0.07924962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01949374199747889,"score_gpt":0.2906815294483955,"score_spread":0.2711877874509167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}